Notably, HCC with high expression of APOA2 relied on TGF-β to promote cell proliferation and angiogenesis, and pharmacological loss of TGF-β function can reduce angiogenesis and malignant tumor proliferation. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.